Medirom Healthcare Technologies Stock Price Patterns

MRM Stock  USD 1.53  0.14  8.38%   
As of now, the relative strength index (RSI) of Medirom Healthcare's share price is approaching 33. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Medirom Healthcare, making its price go up or down.

Momentum 33

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Medirom Healthcare's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Medirom Healthcare and does not consider all of the tangible or intangible factors available from Medirom Healthcare's fundamental data. We analyze noise-free headlines and recent hype associated with Medirom Healthcare Technologies, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Medirom Healthcare's stock price prediction:
Quarterly Earnings Growth
0.278
Wall Street Target Price
5.1224
Quarterly Revenue Growth
(0.07)
Using Medirom Healthcare hype-based prediction, you can estimate the value of Medirom Healthcare Technologies from the perspective of Medirom Healthcare response to recently generated media hype and the effects of current headlines on its competitors.

Medirom Healthcare Hype to Price Pattern

Investor biases related to Medirom Healthcare's public news can be used to forecast risks associated with an investment in Medirom. The trend in average sentiment can be used to explain how an investor holding Medirom can time the market purely based on public headlines and social activities around Medirom Healthcare Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Medirom Healthcare's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Medirom Healthcare.
The fear of missing out, i.e., FOMO, can cause potential investors in Medirom Healthcare to buy its stock at a price that has no basis in reality. In that case, they are not buying Medirom because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Medirom Healthcare after-hype prediction price

    
  USD 1.53  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Medirom Healthcare Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.071.454.47
Details
Naive
Forecast
LowNextHigh
0.031.674.69
Details
1 Analysts
Consensus
LowTargetHigh
4.665.125.69
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.511.842.16
Details

Medirom Healthcare After-Hype Price Density Analysis

As far as predicting the price of Medirom Healthcare at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medirom Healthcare or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medirom Healthcare, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Medirom Healthcare Estimiated After-Hype Price Volatility

In the context of predicting Medirom Healthcare's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medirom Healthcare's historical news coverage. Medirom Healthcare's after-hype downside and upside margins for the prediction period are 0.08 and 4.55, respectively. We have considered Medirom Healthcare's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.53
1.53
After-hype Price
4.55
Upside
Medirom Healthcare is very risky at this time. Analysis and calculation of next after-hype price of Medirom Healthcare is based on 3 months time horizon.

Medirom Healthcare Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Medirom Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medirom Healthcare backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medirom Healthcare, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.34 
2.93
  0.04 
  0.04 
16 Events / Month
6 Events / Month
In about 16 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.53
1.53
0.00 
2,442  
Notes

Medirom Healthcare Hype Timeline

On the 30th of January Medirom Healthcare is traded for 1.53. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.04. Medirom is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at -0.34%. %. The volatility of related hype on Medirom Healthcare is about 2236.64%, with the expected price after the next announcement by competition of 1.57. About 26.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Considering the 90-day investment horizon the next projected press release will be in about 16 days.
Check out Medirom Healthcare Basic Forecasting Models to cross-verify your projections.

Medirom Healthcare Related Hype Analysis

Having access to credible news sources related to Medirom Healthcare's direct competition is more important than ever and may enhance your ability to predict Medirom Healthcare's future price movements. Getting to know how Medirom Healthcare's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medirom Healthcare may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BYAHPark Ha Biological 0.00 5 per month 0.00 (0.23) 7.14 (10.00) 38.67 
SONDSonder Holdings 0.12 17 per month 24.50  0.10  67.74 (61.54) 2,000 
YYGHYY Group Holding(0.01)8 per month 0.00 (0.07) 8.33 (8.33) 30.95 
DSSDSS Inc(0.48)34 per month 0.00 (0.05) 10.00 (6.30) 22.05 
BTBDBt Brands 0.04 23 per month 0.00 (0.06) 7.25 (8.55) 25.61 
ATERAterian 0.09 12 per month 0.00 (0.10) 7.14 (7.14) 28.48 
LOBOLOBO EV TECHNOLOGIES 0.03 8 per month 0.00 (0.05) 13.64 (11.63) 47.21 
FLYEFly E Group Common 0.16 9 per month 11.97  0.04  21.57 (20.17) 284.75 
FGIFGI Industries 1.36 6 per month 7.69  0.05  16.30 (14.12) 50.77 
CENNCenntro Electric Group 0.00 3 per month 0.00 (0.06) 13.33 (6.67) 24.81 

Medirom Healthcare Additional Predictive Modules

Most predictive techniques to examine Medirom price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medirom using various technical indicators. When you analyze Medirom charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Medirom Healthcare Predictive Indicators

The successful prediction of Medirom Healthcare stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medirom Healthcare Technologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medirom Healthcare based on analysis of Medirom Healthcare hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medirom Healthcare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medirom Healthcare's related companies.
 2023 2024 2025 2026 (projected)
Payables Turnover38.195.976.866.52
Days Of Inventory On Hand9.729.148.238.64

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out Medirom Healthcare Basic Forecasting Models to cross-verify your projections.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Will Health Care Providers & Services sector continue expanding? Could Medirom diversify its offerings? Factors like these will boost the valuation of Medirom Healthcare. Expected growth trajectory for Medirom significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Medirom Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.278
Earnings Share
0.39
Revenue Per Share
1.2 K
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.02)
Understanding Medirom Healthcare requires distinguishing between market price and book value, where the latter reflects Medirom's accounting equity. The concept of intrinsic value—what Medirom Healthcare's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Medirom Healthcare's price substantially above or below its fundamental value.
Understanding that Medirom Healthcare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medirom Healthcare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medirom Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.